Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation.

作者: Christoph L. Menzel , Qian Sun , Patricia A. Loughran , Hans-Christoph Pape , Timothy R. Billiar

DOI: 10.2119/MOLMED.2011.00015

关键词:

摘要: Adaptive immune responses are induced in liver after major stresses such as hemorrhagic shock (HS) and trauma. There is emerging evidence that the inflammasome, multiprotein platform induces caspase-1 activation promotes interleukin (IL)-1β IL-18 processing, activated response to cellular oxidative stress, hypoxia, ischemia HS. Additionally, damage-associated molecular patterns, those released injury, have been shown activate inflammasome through NOD-like receptor (NLR) NLRP3. However, role of organ injury HS trauma unknown. We therefore investigated inflammatory end-organ wild-type (WT) caspase-1−/− mice our model with bilateral femur fracture (HS/BFF). found had higher levels systemic cytokines than WT mice. This result corresponded damage, cell death neutrophil influx compared WT, although there was no difference lung damage between experimental groups. To determine if hepatoprotection also depended on NLRP3, we subjected NLRP3−/− HS/BFF, but these similar WT. Hepatoprotection not due caspase-1-dependent cytokines, IL-1β IL-18. Altogether, data suggest hepatoprotective, part regulation pathways trauma, HS/BFF does depend These findings may implications for treatment patients lead progress prevention or multiple failure (MOF).

参考文章(32)
F. Hildebrand, H.-C. Pape, C. Krettek, Die Bedeutung der Zytokine in der posttraumatischen Entzündungsreaktion Unfallchirurg. ,vol. 108, pp. 793- 803 ,(2005) , 10.1007/S00113-005-1005-1
Runkuan Yang, Tomoyuki Harada, Kevin P. Mollen, Jose M. Prince, Ryan M. Levy, Joshua A. Englert, Margot Gallowitsch-Puerta, LiHong Yang, Huan Yang, Kevin J. Tracey, Brian G. Harbrecht, Timothy R. Billiar, Mitchell P. Fink, Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Molecular Medicine. ,vol. 12, pp. 105- 114 ,(2006) , 10.2119/2006-00010.YANG
Keisuke Kuida, Keisuke Kuida, Charles A. Dinarello, Charles A. Dinarello, George Ku, Matthew W. Harding, Jean D. Sipe, David J. Livingston, Richard A. Flavell, Giamila Fantuzzi, Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. Journal of Immunology. ,vol. 158, pp. 1818- 1824 ,(1997)
K Kuida, J. Lippke, G Ku, M. Harding, D. Livingston, M. Su, R. Flavell, Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme Science. ,vol. 267, pp. 2000- 2003 ,(1995) , 10.1126/SCIENCE.7535475
Eicke Latz, The inflammasomes: mechanisms of activation and function. Current Opinion in Immunology. ,vol. 22, pp. 28- 33 ,(2010) , 10.1016/J.COI.2009.12.004
Kaoru Geddes, João G. Magalhães, Stephen E. Girardin, Unleashing the therapeutic potential of NOD-like receptors Nature Reviews Drug Discovery. ,vol. 8, pp. 465- 479 ,(2009) , 10.1038/NRD2783
Adam S. Paszkowski, Bettina Rau, Jens M. Mayer, Peter Möller, Hans G. Beger, Therapeutic Application of Caspase 1/Interleukin-1β-Converting Enzyme Inhibitor Decreases the Death Rate in Severe Acute Experimental Pancreatitis Annals of Surgery. ,vol. 235, pp. 68- 76 ,(2002) , 10.1097/00000658-200201000-00009
Tessa Bergsbaken, Susan L. Fink, Brad T. Cookson, Pyroptosis: host cell death and inflammation Nature Reviews Microbiology. ,vol. 7, pp. 99- 109 ,(2009) , 10.1038/NRMICRO2070
Jerry Shen, Ying Yin, Jietang Mai, Xinyu Xiong, Meghana Pansuria, Jingshan Liu, Erin Maley, Najam Us Saqib, Hong Wang, Xiao-Feng Yang, Caspase-1 recognizes extended cleavage sites in its natural substrates Atherosclerosis. ,vol. 210, pp. 422- 429 ,(2010) , 10.1016/J.ATHEROSCLEROSIS.2009.12.017
Giang Le, Giovanni Abbenante, Inhibitors of TACE and Caspase-1 as anti-inflammatory drugs Current Medicinal Chemistry. ,vol. 12, pp. 2963- 2977 ,(2005) , 10.2174/092986705774462851